Datasheet is currently unavailable. Try again or CONTACT US
ERK1 phosphoT202-pY204 hu recomb protein
009-001-GP8
10 µg
Liquid (sterile filtered)
Human
Sf9 cells
This product is discontinued
Product Details
ERK1 pT202-pY204 human recombinant protein - 009-001-GP8
MAPK3, ERK, ERK1, PRKM3, ERK-1 Antibody, MAPK1, ERK-2, ERK2, MAPK2, P42MAPK, PRKM1, PRKM2, ERK-2 recombinant protein
Human
Sf9 cells
Recombinant Protein
Target Details
MAPK3 - View All MAPK3 Products
Dual Modification
ERK1 pT202-pY204 is a recombinant protein containing a polyhistidine tag expressed in Sf9. ERK1 was phosphorylated in vitro using the activated MEK. Analysis by SDS-PAGE resulted in a pattern consistent with purified ERK1 and was estimated to be greater than 90% pure.
P27361 - UniProtKB
Application Details
ERK1 pT202-pY204 is an activated recombinant protein suitable as a control for polyclonal or monoclonal anti-ERK in immunological assays. ERK1 can be activated by in vitro phosphorylation by MEK proteins. For western blot use at 50 ng or less. For other assays concentration is user optimized.
Formulation
None
Shipping & Handling
Dry Ice
Store vial at -20° C prior to opening. This product is stable at 4° C as an undiluted liquid. For extended storage, aliquot contents and freeze at -20° C or below. Avoid cycles of freezing and thawing. Dilute only prior to immediate use.
Expiration date is one (1) year from date of receipt.
ERK1 pT202-pY204 activated recombinant protein was produced in Sf9 cells. Mitogen activated protein kinase 3, also known as MAPK3, ERK, or ERK1, is an integral component of the MAP kinase cascade that regulates cell growth and differentiation. This pathway also plays a key role in synaptic plasticity in the brain. This recombinant protein is the activated ERK1 isoform and is ideal for investigators involved in Neuroscience, Cell Signaling and Cancer Research.
This product is for research use only and is not intended for therapeutic or diagnostic applications. Please contact a technical service representative for more information. All products of animal origin manufactured by Rockland Immunochemicals are derived from starting materials of North American origin. Collection was performed in United States Department of Agriculture (USDA) inspected facilities and all materials have been inspected and certified to be free of disease and suitable for exportation. All properties listed are typical characteristics and are not specifications. All suggestions and data are offered in good faith but without guarantee as conditions and methods of use of our products are beyond our control. All claims must be made within 30 days following the date of delivery. The prospective user must determine the suitability of our materials before adopting them on a commercial scale. Suggested uses of our products are not recommendations to use our products in violation of any patent or as a license under any patent of Rockland Immunochemicals, Inc. If you require a commercial license to use this material and do not have one, then return this material, unopened to: Rockland Inc., P.O. BOX 5199, Limerick, Pennsylvania, USA.
